• editas medicine appoints pwc as new auditor, dismisses ernst & young Investing.com Sat, 04 Jul 2026 15:11:19 GMT
• Editas Medicine stock holds the line as pipeline work continues. AD HOC NEWS Fri, 03 Jul 2026 19:41:59 GMT
• Editas Medicine, Inc.(NasdaqGS:EDIT) added to Russell Small Cap Comp Growth Benchmark marketscreener.com Mon, 29 Jun 2026 20:56:08 GMT
• Editas Medicine, Inc.(NasdaqGS: EDIT) added to Russell 2500 Growth Benchmark marketscreener.com Mon, 29 Jun 2026 19:28:54 GMT
• editas medicine, inc.(nasdaqgs: edit) added to russell microcap growth benchmark index marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• Price to sales forward of Editas Medicine, Inc. – NASDAQ:EDIT TradingView Sun, 28 Jun 2026 03:59:13 GMT
• enterprise value to ebitda forward of editas medicine, inc. – nasdaq:edit TradingView Sat, 27 Jun 2026 14:28:40 GMT
• price to earnings forward of editas medicine, inc. – lse:0ifk TradingView Sat, 27 Jun 2026 10:04:24 GMT
• enterprise value to revenue forward of editas medicine, inc. – nasdaq:edit TradingView Sat, 27 Jun 2026 08:12:37 GMT
• price to book forward of editas medicine, inc. – nasdaq:edit TradingView Sat, 27 Jun 2026 04:17:58 GMT
• editas medicine inc (edit) technical analysis: support, resistance, indicators & moving averages TradingKey Fri, 26 Jun 2026 06:48:15 GMT
• editas medicine inc (edit) valuation: pe, pb & fair value analysis TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• editas medicine | 4: statement of changes in beneficial ownership of securities-director scadden david Moomoo Tue, 23 Jun 2026 17:37:28 GMT
• editas medicine inc (edit) financial health: profitability & balance sheet analysis TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• editas medicine | 4: statement of changes in beneficial ownership of securities-director hirsch andrew Moomoo Mon, 22 Jun 2026 20:30:46 GMT
• editas medicine (edit) director granted 51,700 stock options at $2.55 strike Stock Titan Mon, 22 Jun 2026 20:29:20 GMT
• Editas Medicine (EDIT) director Andrew Hirsch awarded 51,700 stock options Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• Editas Medicine (EDIT) director awarded 51,700 stock options at $2.55 strike Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• Editas Medicine (NASDAQ: EDIT) director granted 51,700 stock options at $2.55 Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• form 4 editas medicine for: 22 june by investing.com Investing.com UK Mon, 22 Jun 2026 07:00:00 GMT
• editas medicine inc (edit) earnings forecast: future eps & revenue growth estimates TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• editas medicine pivots to in vivo gene editing as shares recover from yearly nadir AD HOC NEWS Fri, 19 Jun 2026 17:13:16 GMT
• Editas Medicine elects two directors and ratifies auditor at annual meeting Investing.com India Fri, 19 Jun 2026 07:00:00 GMT
• editas medicine inc (edit) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 12:18:44 GMT
• Editas Medicine Inc (EDIT) Shareholder Structure: Major Shareholders & Institutional Holdings TradingKey Thu, 18 Jun 2026 09:58:28 GMT
• Editas Medicine Inc (EDIT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Thu, 18 Jun 2026 09:54:09 GMT
• Editas Medicine (NASDAQ: EDIT) stockholders elect directors and ratify PwC at 2026 meeting Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• editas medicine inc (edit) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 22:53:58 GMT
• editas medicine inc (edit) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 22:53:56 GMT
• editas medicine inc (edit) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 22:52:59 GMT
• editas medicine inc (edit) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 22:23:23 GMT
• editas medicine inc annual shareholders meeting transcript GuruFocus Wed, 17 Jun 2026 12:30:00 GMT
• editas medicine inc (edit) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 07:00:00 GMT
• editas medicine inc (edit) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• editas medicine inc (edit) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• editas medicine inc (edit) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• crispr therapeutics vs. editas medicine: which gene editing stock is a better buy in 2026? AOL.com Tue, 09 Jun 2026 18:09:06 GMT
• crispr therapeutics vs. editas medicine: which gene editing stock is a better buy in 2026? AOL.com Mon, 08 Jun 2026 17:54:54 GMT
• crispr therapeutics vs. editas medicine: which gene editing stock is a better buy in 2026? AOL.com Sun, 07 Jun 2026 10:30:02 GMT
• Editas Medicine Shares Slide 9.36%: Key Support Levels in Focus - Jelly Roll Trade dars.gov.et Sun, 07 Jun 2026 07:00:00 GMT
• editas medicine ceo gilmore o’neill sells $41,542 in stock by investing.com Investing.com India Sat, 06 Jun 2026 07:00:00 GMT
• ra capital management, l.p. acquires significant stake in editas medicine inc GuruFocus Sat, 06 Jun 2026 04:57:07 GMT
• commodore capital lp acquires significant stake in editas medici GuruFocus Sat, 06 Jun 2026 04:21:37 GMT
• Editas Medicine CEO Gilmore O’Neill sells $41,542 in stock Investing.com Fri, 05 Jun 2026 07:00:00 GMT
• Editas Medicine (EDIT) CEO logs automatic, tax-related share sale Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• Editas Medicine (EDIT) CSO sells 731 shares under automatic tax-cover plan Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• Editas Medicine (EDIT) CFO logs small automatic tax-related share sale Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• editas medicine | 4: statement of changes in beneficial ownership of securities-officer o'neill gilmore neil Moomoo Fri, 05 Jun 2026 07:00:00 GMT
• ra capital management, l.p. acquires significant stake in editas medicine inc GuruFocus Fri, 05 Jun 2026 07:00:00 GMT
• Why Is Editas (EDIT) Down 12.4% Since Last Earnings Report? Yahoo Finance Thu, 04 Jun 2026 07:00:00 GMT
• edit: edit-401 shows durable 90% ldl and lp(a) reduction, with clinical trials starting in 2024 TradingView Thu, 04 Jun 2026 07:00:00 GMT
• Editas Medicine (EDIT) Declines 1.95% as Gene Editing Stock Approaches Key Support - MESA MA dars.gov.et Wed, 03 Jun 2026 07:00:00 GMT
• ra capital affiliates report 8.89m shares in editas medicine (edit) Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• tcg crossover group reports 9.9% stake in editas medicine (edit) after offering Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• editas medicine inc stock (us28106w1036): q1 2026 loss narrows as nasdaq-listed gene-editing player AD HOC NEWS Tue, 02 Jun 2026 20:36:29 GMT
• Commodore reports 16.05M-share position in Editas Medicine (EDIT) under 9.99% cap Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• genome editing market to reach $13.36 billion by 2035, growing openPR.com Tue, 02 Jun 2026 04:41:23 GMT
• CRISPR Therapeutics vs. Editas Medicine: Which Gene Editing Stock Is a Better Buy in 2026? The Motley Fool Sun, 31 May 2026 07:00:00 GMT
• Market Watch Rx: Editas Medicine Leads Gainers Pharmaceutical Executive Fri, 29 May 2026 07:00:00 GMT
• EDIT (NASDAQ) insider notice: 15,000-share resale; 32,957 RSUs vested Stock Titan Fri, 29 May 2026 07:00:00 GMT
• editas medicine inc stock (us28106w1036): nasdaq gene-editing share trades quietly ahead of next cat AD HOC NEWS Fri, 29 May 2026 07:00:00 GMT
• gene editing firm editas to webcast jefferies talk june 4 live Stock Titan Thu, 28 May 2026 20:01:00 GMT
• Editas Medicine: Resetting Pipeline Just To Be Second To Market Again (NASDAQ:EDIT) Seeking Alpha Thu, 28 May 2026 07:00:00 GMT
• Editas Medicine Announces Updated Presentation Time for Upcoming Investor Conference GlobeNewswire Thu, 28 May 2026 07:00:00 GMT
• q2 eps estimates for editas medicine raised by hc wainwright MarketBeat Thu, 28 May 2026 07:00:00 GMT
• editas medicine (edit) unveils promising data for edit-401 GuruFocus Wed, 27 May 2026 18:39:16 GMT
• editas medicine (edit) showcases promising preclinical findings GuruFocus Wed, 27 May 2026 18:33:45 GMT
• editas medicine announces $319.4 million public offering with crispr gene editing focus Minichart Wed, 27 May 2026 13:28:00 GMT
• evercore maintains editas medicine(edit.us) with buy rating, maintains target price $15 Moomoo Wed, 27 May 2026 07:00:00 GMT
• editas medicine (edit) initiates public offering of common stock GuruFocus Tue, 26 May 2026 15:02:51 GMT
• editas medicine (edit) shares drop following stock offering anno GuruFocus Tue, 26 May 2026 14:52:50 GMT
• editas presents powerful preclinical data for hyperlipidemia therapy grafa.com Tue, 26 May 2026 14:19:00 GMT
• editas medicine (edit) showcases promising preclinical findings for edit-401 GuruFocus Tue, 26 May 2026 11:11:05 GMT
• editas medicine proposes public stock offering; shares fall pre-bell Moomoo Tue, 26 May 2026 10:38:30 GMT
• editas medicine (nasdaq: edit) offers common shares, pre-funded warrants and detachable warrants Stock Titan Tue, 26 May 2026 10:27:03 GMT
• Editas Medicine Announces Promising Preclinical Results for EDIT-401, Showcasing Significant Reductions in LDL-C, Lp(a), and ApoB ... Quiver Quantitative Tue, 26 May 2026 07:00:00 GMT
• Editas Medicine Announces Pricing of Up to $319.4 Million Public Offering GlobeNewswire Tue, 26 May 2026 07:00:00 GMT
• Editas offering links warrant window to cholesterol trial results Stock Titan Tue, 26 May 2026 07:00:00 GMT
• Editas Medicine stock tumbles on stock offering announcement Investing.com Tue, 26 May 2026 07:00:00 GMT
• Editas Medicine launches public offering of stock and warrants Investing.com Tue, 26 May 2026 07:00:00 GMT
• Editas Medicine prices $125M stock offering with warrants By Investing.com Investing.com Nigeria Tue, 26 May 2026 07:00:00 GMT
• One-shot gene edit slashes multiple cholesterol drivers in animal tests Stock Titan Tue, 26 May 2026 07:00:00 GMT
• Editas Medicine (NASDAQ: EDIT) sells 55.6M shares with warrants to fund EDIT-401 Stock Titan Tue, 26 May 2026 07:00:00 GMT
• Editas Medicine (NASDAQ: EDIT) halts sales under TD Cowen ATM prospectus Stock Titan Tue, 26 May 2026 07:00:00 GMT
• Editas Medicine Presents EDIT-401 Preclinical Data Showing ~90% Cuts in LDL-C, Lp(a), and ApoB; CTN Planned Mid-2026 TradingView Tue, 26 May 2026 07:00:00 GMT
• Cartesian secures funding to ‘accelerate’ launch; Editas sells $125M in stock Endpoints News Tue, 26 May 2026 07:00:00 GMT
• gene-editing firm editas moves to sell new shares and warrants Stock Titan Tue, 26 May 2026 07:00:00 GMT
• biopharma bites: astellas' five-year strategy, funding for editas, cartesian FirstWord Pharma Tue, 26 May 2026 07:00:00 GMT
• editas reports preclinical data for gene editing treatment Investing.com Tue, 26 May 2026 07:00:00 GMT
• editas medicine (nasdaq: edit) prices equity deal, extends cash runway to 2h 2028 Stock Titan Tue, 26 May 2026 07:00:00 GMT
• edit-401 gene-editing data and trial path at editas medicine (nasdaq: edit) Stock Titan Tue, 26 May 2026 07:00:00 GMT
• h.c. wainwright maintains editas medicine(edit.us) with buy rating, maintains target price $5 Moomoo Tue, 26 May 2026 07:00:00 GMT
• editas medicine q1 2026 earnings: narrower-than-expected loss boosts investor sentiment - earnings risk report thelegaladvocate.com Sat, 23 May 2026 07:00:00 GMT
• editas medicine stock (us28106w1036): recent clinical updates keep investors focused AD HOC NEWS Thu, 21 May 2026 07:00:00 GMT
• editas medicine unveils new data on edit-401 for hyperlipidemia Intellectia AI Wed, 20 May 2026 18:57:23 GMT
• jonestrading maintains editas medicine(edit.us) with buy rating, raises target price to $8 Moomoo Fri, 15 May 2026 08:17:23 GMT
• analyst forecasts just became more bearish on editas medicine, inc. (nasdaq:edit) Moomoo Fri, 15 May 2026 07:00:00 GMT
• edit stock price, quote & chart | editas medicine inc (nasdaq:edit) ChartMill Fri, 15 May 2026 07:00:00 GMT
• stockwatch: after 1- and 6-month gains, gene editing companies await q3 results: Sage Journals Thu, 14 May 2026 18:46:17 GMT
• editas medicine reports durable ≥90% ldl-c reduction with single dose of edit-401 in preclinical hyperlipidemia data at asgct 2026... Minichart Thu, 14 May 2026 18:17:00 GMT
• editas medicine stock (us28106w1036): edit-401 shows 90% ldl reduction in preclinical study AD HOC NEWS Thu, 14 May 2026 18:08:08 GMT
• jonestrading maintains editas medicine(edit.us) with buy rating, raises target price to $8 富途牛牛 Thu, 14 May 2026 16:40:05 GMT
• editas medicine (edit) advances gene editing candidate for hyper GuruFocus Thu, 14 May 2026 15:22:30 GMT
• editas showcases promising edit-401 hyperlipidemia preclinical data TipRanks Thu, 14 May 2026 11:22:25 GMT
• editas medicine’s edit-401 shows efficacy and safety in hyperlipidemia TipRanks Thu, 14 May 2026 10:31:20 GMT
• editas reports ≥90% mean ldl-c reduction with single edit-401 dose in nhps; durable ~6 months TradingView Thu, 14 May 2026 10:23:00 GMT
• Analyst Forecasts Just Became More Bearish On Editas Medicine, Inc. (NASDAQ:EDIT) simplywall.st Thu, 14 May 2026 07:00:00 GMT
• Editas Medicine Reports New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at the A... Yahoo Finance Thu, 14 May 2026 07:00:00 GMT
• Editas Medicine presents preclinical data on EDIT-401 therapy Investing.com Thu, 14 May 2026 07:00:00 GMT
• editas medicine presents edit-401 preclinical data at asgct 2026 for hyperlipidemia treatment geneonline.com Thu, 14 May 2026 07:00:00 GMT
• gene editing test from editas cuts ldl cholesterol 90% in monkeys Stock Titan Thu, 14 May 2026 07:00:00 GMT
• edit-401 preclinical data show ≥90% ldl-c drop in primates (edit) Stock Titan Thu, 14 May 2026 07:00:00 GMT
• editas medicine presents new in vivo gene editing data on edit-401 at tides usa 2026 meeting Traders Union Wed, 13 May 2026 11:38:20 GMT
• editas medicine unveils cardiovascular research at asgct and tides usa events Traders Union Mon, 11 May 2026 14:42:42 GMT
• Some Analysts Just Cut Their Editas Medicine, Inc. (NASDAQ:EDIT) Estimates Yahoo Finance Mon, 11 May 2026 07:00:00 GMT
• edit technical analysis | trend, signals & chart patterns | editas medicine inc (nasdaq:edit) ChartMill Mon, 11 May 2026 07:00:00 GMT
• editas medicine (nasdaq:edit) rating lowered to "sell" at wall street zen MarketBeat Sun, 10 May 2026 07:00:00 GMT
• editas medicine inc. (edit) stock price | live quotes & charts | nasdaq StocksToTrade Fri, 08 May 2026 23:59:00 GMT
• analysts offer insights on healthcare companies: brookdale senior living (bkd), tempus ai, inc. class a (tem) and editas medicine ... The Globe and Mail Fri, 08 May 2026 18:56:35 GMT
• Earnings Update: Editas Medicine, Inc. (NASDAQ:EDIT) Just Reported And Analysts Are Boosting Their Estimates simplywall.st Fri, 08 May 2026 07:00:00 GMT
• editas medicine, inc. (nasdaq:edit) receives consensus recommendation of "moderate buy" from brokerages MarketBeat Fri, 08 May 2026 07:00:00 GMT
• bofa securities maintains editas medicine(edit.us) with sell rating 富途牛牛 Fri, 08 May 2026 01:41:33 GMT
• bofa securities maintains editas medicine(edit.us) with sell rating 富途牛牛 Thu, 07 May 2026 07:00:00 GMT
• editas medicine (edit) reports q1 loss, misses revenue estimates MSN Thu, 07 May 2026 02:34:06 GMT
• rbc capital maintains editas medicine(edit.us) with hold rating, maintains target price $4 富途牛牛 Thu, 07 May 2026 01:31:05 GMT
• rbc capital maintains editas medicine(edit.us) with hold rating, maintains target price $4 Moomoo Wed, 06 May 2026 18:31:00 GMT
• analysts offer insights on healthcare companies: editas medicine (edit), vertex pharmaceuticals (vrtx) and sotera health (shc) The Globe and Mail Wed, 06 May 2026 12:57:08 GMT
• edit's q1 loss narrower than expected, pipeline in focus Yahoo Finance Wed, 06 May 2026 07:00:00 GMT
• editas medicine ceo gilmore o’neill sells $41,542 in stock by investing.com Investing.com Nigeria Wed, 06 May 2026 07:00:00 GMT
Editas Medicine, Inc(NASDAQ:EDIT) 
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary genome editing platform based on CRISPR technology to target genetically addressable diseases and therapeutic areas. ...
Website: http://www.editasmedicine.com
Founded: 2013
Full Time Employees: 208
Sector: Healthcare
Industry: Biotechnology